Актуальность применения психотропных препаратов в клинической онкологии
- Авторы: Зубкова Ю.Н1, Курмуков И.А1, Обухова О.А1, Кашия Ш.Р1
-
Учреждения:
- Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина
- Выпуск: № 12 (2018)
- Страницы: 14-20
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/295789
- DOI: https://doi.org/10.18565/pharmateca.2018.12.14-20
- ID: 295789
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Ю. Н Зубкова
Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина
Email: Москва. Россия;e-mail: kostenay@mail.ru
врач-психиатр, отдел функциональной диагностики, интенсивной терапии и реабилитации
И. А Курмуков
Национальный медицинский исследовательский центр онкологии им. Н.Н. БлохинаОтдел функциональной диагностики, интенсивной терапии и реабилитации
О. А Обухова
Национальный медицинский исследовательский центр онкологии им. Н.Н. БлохинаОтдел функциональной диагностики, интенсивной терапии и реабилитации
Ш. Р Кашия
Национальный медицинский исследовательский центр онкологии им. Н.Н. БлохинаОтдел функциональной диагностики, интенсивной терапии и реабилитации
Список литературы
- Henry G.W. Some modern aspects of psychiatry in general hospital practice. Am. J. Psychiatry 1929;86:481-99
- Lipowski Z.J. Consultation-liaison psychiatry at century's end. Psychosomatics. 1992;33:128-33. doi: 10.1176/ajp.131.6.623
- Patterson K.R. Psycho-Oncology. In: Psychosomatic medicine. K.D. Ackerman, A.F. DiMartini (ed.). Oxford; New York: Oxford University Press, 2015
- Смулевич А.Б. Психосоматические расстройства в онкологии. Эффективная фармакотерапия. 2009;18:28-9. [Smulevich A.B. Psychosomatic disorders in oncology Effektivnaya farmakoterapiya. 2009;18:28-9. (In Russ.)].
- Sutherland A.M. Psychological impact of cancer and its therapy. Med. Clin. North Am. 1956;40(3):705-20.
- Plumb M., Holland J. Comparative studies of psychological function in patients with advanced cancer -I Self-reported depressive symptoms. Psychosom. Med. 1977;39:264-76.
- Maguire G.P., Lee E.G., Bevington D.J., et. al. Psychiatric problems in the first year after mastectomy. Br. Med. J. 1978;15(1):963-65.
- Plumb M., Holland J. Comparative studies of psychological function in patients with advanced cancer II. Interviewer-rated current and past psychological symptoms. Psychosom. Med. 1981;43:243-54.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). Washington, D.C.: American Psychiatric Publishing, 1980. 494 p.
- Derogatis L.R., Morrow G.R., Fetting J., et al. The prevalence of psychiatric disorders among cancer patient. JAMA. 1983;249(6):751-57.
- Hardman A., Maguire P., Crowther D. The recognition of psychiatric morbidity on a medical oncology ward. J. Psychosom. Res. 1989;33:235-39.
- Razavi D., Delvaux N., Farvacques C., Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br. J. Psychiatry. 1990;156:79-83.
- Grassi L., Rosti G., Lasalvia A., Marangolo M. Psychosocial variables associated with mental adjustment to cancer. Psycho-Oncology. 1993;2:11-20.
- Grassi L., Gritti P., Rigatelli M., Gala C. Psychosocial problems secondary to cancer: an Italian multicenter survey of consultation-liason psychiatry in oncology. Eur. J. Cancer. 2000;36:579-85.
- Kissane D.W., Grabsch B., Love A., et al. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust. N. Z. J. Psychiatry. 2004;38:320-6. PMID: 9734576.
- Prieto J.M., Blanch J., Atala J., et al. C. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J. Clin. Oncol. 2002;20:1907-17.
- Singer S., Szalai C., Briest S., et al. Co-morbid mental health conditions in cancer patients at working age - prevalence, risk profiles, and care uptake. Psychooncology. 2013;22(10):2291-97. doi: 10.1002/pon.3282.
- Singer S., Das- Munshi J., Brachler E. Prevalence of mental health conditions in cancer patients in acute care-a meta-analysis. Ann. Oncol. 2010;21:925 30. doi: 10.1093/annonc/mdp515
- Mitchell A.J., Chan M., Bhatti H., et al. Prevalence of depression, anxiety, and adjustment disorders in oncological, hematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet. Oncol. 2011;12:160-74.
- Miovic M., Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110:1665-76. doi: 10.1002/cncr.22980.
- Смулевич А.Б., Андрющенко А.В., Бескова Д.А. Психические расстройства в онкологии (результаты мультицентровой программы «Синтез»). Психические расстройства в общей медицине. 2009;1:4-12.
- Derogatis L.R., Feldstein M., Morrow G., et al. A survey of psychotropic drug prescriptions in an oncology population. Cancer. 1979;44:1919-29.
- Jaeger H., Morrow G.R., Carpenter P.J., Brescia F. A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp. Psyciatry. 1985;7:353-60.
- Stiefel F.C., Kornblith A.B., Holland J.C. Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer. 1990;65:1048-53.
- Thekdi S.M., Irarrazaval M.E., Dunn L. Psychopharmacological interventions. In: Grassi L., Riba M., editors. Clinical psycho-oncology:an international perspective. Chichester: Wiley, 2012. P. 109-26.
- Caruso R., Grassi L., Nanni M.G., Riba M. Psychopharmacology in psycho-oncology. Curr. Psychiatry Rep. 2013;15(9):393. Doi:10.1007/ s11920-013-0393-0.
- Farriols C., Ferrandez O., Planas J., et al. Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. J. Pain Sympton. Manage. 2012;43:945-52. Doi: 10.1016/j. jpainsymman.2011.05.010.
- Desplenter F., Bond C., Watson M., et al. Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control study. Br. J. Cancer. 2012;107:1644-51. doi: 10.1038/bjc.2012.364.
- De Bock G.H., Musters R.F., Bos H.J., et al. Psychotropoc medication during endocrine treatment for breast cancer. Support Care Cancer. 2012;20:1533-40. doi: 10.1007/s00520-011- 1242-5.
- Ng C.G., Boks M.P., Smeets H.M., et al. Prescription patterns for psychotripic drugs in cancer patients; a large population study in the Netherlands. Psychology. 2013;22:762-67. Doi: 10.1002/ pon.3056.
- Lindqvist O., Lundquist G., Dickman A., et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J. Palliative Med. 2013;16:38 43. doi: 10.1089/jpm.2012.0205
- Deyell R.J., Lorenzi M., Ma S., et al. Antidepressant use among survives of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatr. Blood Canc. 2013;60:816-22.
- Breitbart W., Alici Y. Evidence-based treatment of delirium in patients with cancer. J. Clin. Oncol. 2012;30:1206-14. Doi:10.1200/ JCO.2011.39.8784.
- Rodin G., Lloyd N., Katz M., et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15(2):123-36.
- Okamura M., Akizuki N., Nakano T., et al. Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychology. 2008;17(2):154-60.
- Rayner L., Price A., Evans A., et al. Antidepressants for treatment of depression in palliative care: systematic review and metaanalysis. Palliat. Med. 2011;25(1):36-51. doi: 10.1177/0269216310380764.
- Rayner L., Price A., Hotopf M., Higginson I.J. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur. J. Cancer. 2011;47(5):702-12. Doi:10.1016/j. ejca.2010.11.027.
- Cowan J.D., Palmer T.W. Practical guide to palliative sedation. Curr. Oncol. Rep. 2002;4(3):242-49.
- Kehl K.A. Treatment of terminal restlessness: a review of the evidence. J. Pain Palliative Care Pharmacother. 2004;18(1):5-30.
- Grassi L., Caruso R., Hammelef K., et al. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int. Rev. Psychiatry 2014;26(1):44-62. doi: 10.3109/09540261.2013.842542.
- Ouwens M., Hulscher M., Hermens R., et al. Implementation of integrated care for patients with cancer: a systematic review of interventions and effects. Int. J. Qual Health Care. 2009;21(2):137 44. doi: 10.1093/intqhc/mzn061
- Ripamonti C., Santini D., Maranzano E., et al. Management of cancer pain: ESMO clinical practice guidelines. Ann. Oncol. 2012;23(7):139-54.
- Bennett M.I. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat. Med. 2011;25:553. doi: 10.1177/0269216310378546.
- Bordeleau L., Pritchard K., Goodwin P., Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-basedreview. Clin. Therapeut. J. 2007;29(2):230-41. doi: 10.1016/j.clinthera.2007.02.006.
- Kast R.E., Foley K. Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. Eur. J. Cancer Care (Engl). 2007;16:351-54. doi: 10.1111/j.1365-2354.2006.00760.x.
- Riechelmann R.P., Burman D., Tannock I.F., et al. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am. J. Hosp. Pallat. Care. 2012;27:106-10. doi: 10.1177/1049909109345685.
- Breitbart W., Alici-Evcimen Y. Update on psychotropic medications for cancer-related fatigue. J. Natl. Compr. Canc. Netw. 2007;5:1081-91.
- Minton O., Richardson A., Sharpe M., et al. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J. Natl. Cancer Inst. 2008;100:1155-66. doi: 10.1093/jnci/djn250.
- Breitbart W., Alici Y. Psychostimulants for cancer-related fatigue. J. Natl. Compr. Canc. Netw. 2010;8:933-42.
- Minton O., Richardson A., Sharpe M., et al. Psychostimulants for the management of cancer-related fatigue: a systematic review and metaanalysis. J. Pain Symptom Manage. 2011;41:761-67. doi: 10.1016/j.jpainsymman.2010.06.020.
- Bennett M.I., Laird B., Van Litsenburg C., Nimour M. Pregabalin for management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med. 2013;5:132-36. doi: 10.1111/pme.12212.